Financial Perspectives, Inc Astrazeneca PLC Transaction History
Financial Perspectives, Inc
- $292 Billion
- Q1 2025
A detailed history of Financial Perspectives, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Perspectives, Inc holds 1,864 shares of AZN stock, worth $133,723. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,864
Previous 1,863
0.05%
Holding current value
$133,723
Previous $122 Million
12.26%
% of portfolio
0.05%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,429Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.1 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.92 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.56 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.28 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.24 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $222B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...